The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Renzi David since year 2005.
The trader's CIK number is 1631294.
At the time of this reporting, Renzi David is the President & CEO of Carbylan Therapeutics, Inc. .
(stock ticker symbol CBYL).
See this page for all insider trading activities at Carbylan Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2016-11-21||CBYL||Carbylan Therapeutics, Inc.||Option Ex||36,640||7.84||287,257|
|2015-12-30||CBYL||Carbylan Therapeutics, Inc.||Sale||10,000||3.70||37,000|
|2015-12-30||CBYL||Carbylan Therapeutics, Inc.||Option Ex||10,000||.56||5,600|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Renzi David (President & CEO of Carbylan Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.